Sign in Register

Publications

Stay up to date with our literature reviews which are curated by experts to feature the most important publications released each month. Explore our publications for access to concise summary slides for your own use.

Early Benefit With Empagliflozin in Heart Failure With Preserved Ejection Fraction: Insights From the EMPEROR-Preserved Trial

Butler J,

Siddiqi TJ,

Filippatos G,

Ferreira JP,

Pocock SJ,

Zannad F,

Anker SD

Eur J Heart Fail 2022;24(2):245–8. doi:10.1002/ejhf.2420

EMPEROR-Preserved was the first trial in HFpEF to meet its primary endpoint. In this viewpoint article, Butler et al discuss the results of this key study.